Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
Virtual Webcast to be Held Monday, September 14, 2026, at 8:00 AM EDTNORWOOD, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP, a clinical-stage company focused on developing new therapies in oncology and obesity, today announced that the Company’s managem…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.